{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:26:20Z","timestamp":1783445180727,"version":"3.54.6"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371304"],"award-info":[{"award-number":["32371304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014881","name":"Guangzhou University","doi-asserted-by":"publisher","award":["JCCX2024 \\u2013017"],"award-info":[{"award-number":["JCCX2024 \\u2013017"]}],"id":[{"id":"10.13039\/501100014881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neuint.2026.106202","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:44:25Z","timestamp":1781048665000},"page":"106202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An emerging therapeutic strategy for major depressive disorder: targeting the protein-protein interactions"],"prefix":"10.1016","volume":"198","author":[{"given":"Xingyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4276-9251","authenticated-orcid":false,"given":"Yuan-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2026.106202_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(84)91137-5","article-title":"Hyperpolarization of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased K+ conductance","volume":"305","author":"Aghajanian","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2026.106202_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biochi.2018.10.015","article-title":"The 5-HT1A receptor: signaling to behavior","volume":"161","author":"Albert","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.neuint.2026.106202_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/cn3002174","article-title":"Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior","volume":"4","author":"Altieri","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib4","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.3390\/ijms24087467","article-title":"5-HT1AR-FGFR1 heteroreceptor complexes differently modulate GIRK currents in the dorsal hippocampus and the dorsal raphe serotonin nucleus of control rats and of a genetic rat model of depression","volume":"24","author":"Ambrogini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2026.106202_bib5","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/acschemneuro.5b00225","article-title":"Binding of the multimodal antidepressant drug vortioxetine to the human serotonin transporter","volume":"6","author":"Andersen","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/acschemneuro.5b00034","article-title":"5-HT1A receptor-mediated autoinhibition and the control of serotonergic cell firing","volume":"6","author":"Andrade","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archpsyc.1994.03950030084009","article-title":"Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors","volume":"51","author":"Artigas","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0166-2236(96)10037-0","article-title":"Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578728","article-title":"Immunostimulatory and immunomodulatory effects of duloxetine and venlafaxine on p38 MAPK and PI3K pathways","volume":"408","author":"Aydemir","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuint.2026.106202_bib10","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1038\/tp.2015.168","article-title":"A requirement of serotonergic p38\u03b1 mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors","volume":"5","author":"Baganz","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0327(02)00404-4","article-title":"Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials","volume":"79","author":"Ballesteros","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuint.2026.106202_bib12","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-dimethylphenylsulfanyl) phenyl] piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2026.106202_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-2999(96)00999-5","article-title":"EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties","volume":"322","author":"Bartoszyk","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib15","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.1523\/JNEUROSCI.20-20-07571.2000","article-title":"Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A","volume":"20","author":"Bauman","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(92)90292-C","article-title":"Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study","volume":"229","author":"Bel","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuint.2026.106202_bib18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/pr.115.012260","article-title":"Kinase-dependent regulation of monoamine neurotransmitter transporters","volume":"68","author":"Bermingham","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2026.106202_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nature01040","article-title":"Structure of the Sec23\/24\u2013Sar1 pre-budding complex of the COPII vesicle coat","volume":"419","author":"Bi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2026.106202_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(63)92743-0","article-title":"Hypertensive crisis due to monoamine-oxidase inhibitors","volume":"282","author":"Blackwell","year":"1963","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.neuint.2026.106202_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-3223(98)00124-3","article-title":"Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins","volume":"44","author":"Blakely","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.1998.tb10192.x","article-title":"Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission","volume":"861","author":"Blier","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2026.106202_bib23","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mp.2011.92","article-title":"Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects","volume":"17","author":"Bortolozzi","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuint.2026.106202_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5681036","article-title":"Nitric oxide\u2010mediated posttranslational modifications: impacts at the synapse","volume":"2016","author":"Bradley","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuint.2026.106202_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2005-837806","article-title":"Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data","volume":"38","author":"Brambilla","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib26","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1021\/acschemneuro.3c00319","article-title":"Palmitoylation regulates human serotonin transporter activity, trafficking, and expression and is modulated by escitalopram","volume":"14","author":"Brown","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib27","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1021\/acschemneuro.5c00240","article-title":"Modulation of autism-associated serotonin transporters by palmitoylation: insights into the molecular pathogenesis and targeted therapies for autism spectrum disorder","volume":"16","author":"Brown","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2026.106202_bib29","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI33374","article-title":"Interactions between integrin \u03b1IIb\u03b23 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans","volume":"118","author":"Carneiro","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuint.2026.106202_bib30","doi-asserted-by":"crossref","first-page":"24769","DOI":"10.1074\/jbc.M603877200","article-title":"Serotonin-, protein kinase C-, and hic-5-associated redistribution of the platelet serotonin transporter","volume":"281","author":"Carneiro","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuint.2026.106202_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/jpn.0427","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.sleep.2018.05.034","article-title":"Serotonin: its place today in sleep preparation, triggering or maintenance","volume":"49","author":"Cespuglio","year":"2018","journal-title":"Sleep Med."},{"key":"10.1016\/j.neuint.2026.106202_bib34","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1073\/pnas.0610964104","article-title":"Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity","volume":"104","author":"Chanrion","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2026.106202_bib35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/bi962256g","article-title":"External cysteine residues in the serotonin transporter","volume":"36","author":"Chen","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2026.106202_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41401-025-01666-9","article-title":"Esflurbiprofen exerts a fast-onset antidepressant effect by blocking SERT-nNOS interaction","volume":"47","author":"Chen","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuint.2026.106202_bib37","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","article-title":"Anticholinergic activity of 107 medications commonly used by older adults","volume":"56","author":"Chew","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.neuint.2026.106202_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jad.2016.02.042","article-title":"Vortioxetine for major depressive disorder: an indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed","volume":"196","author":"Citrome","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 3","key":"10.1016\/j.neuint.2026.106202_bib39","first-page":"5","article-title":"Recognition and assessment of sexual dysfunction associated with depression","volume":"62","author":"Clayton","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/YIC.0000000000000145","article-title":"Effects of vilazodone on sexual functioning in healthy adults: results from a randomized, double-blind, placebo-controlled, and active-controlled study","volume":"32","author":"Clayton","year":"2017","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib41","first-page":"26","article-title":"A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder","volume":"46","author":"Cohn","year":"1985","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature17629","article-title":"X-ray structures and mechanism of the human serotonin transporter","volume":"532","author":"Coleman","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2026.106202_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-019-1135-1","article-title":"Serotonin transporter\u2013ibogaine complexes illuminate mechanisms of inhibition and transport","volume":"569","author":"Coleman","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2026.106202_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2018.10.018","article-title":"Post-translational modifications of serotonin transporter","volume":"140","author":"Cooper","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuint.2026.106202_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fnbeh.2014.00189","article-title":"A neurobiological hypothesis of treatment-resistant depression \u2013 mechanisms for selective serotonin reuptake inhibitor non-efficacy","volume":"8","author":"Coplan","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addbeh.2018.08.027","article-title":"A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based?","volume":"97","author":"Davies","year":"2019","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuint.2026.106202_bib47","doi-asserted-by":"crossref","first-page":"dev200549","DOI":"10.1242\/dev.200549","article-title":"Sex-biased effects on hippocampal circuit development by perinatal SERT expression in CA3 pyramidal neurons","volume":"149","author":"De Gregorio","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.neuint.2026.106202_bib48","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neubiorev.2006.01.001","article-title":"Serotonin and the neurobiology of the ejaculatory threshold","volume":"30","author":"de Jong","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuint.2026.106202_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.pbr.2021.01.009","article-title":"5-HT\/GABA interaction in neurodevelopment and plasticity","volume":"259","author":"Deidda","year":"2021","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuint.2026.106202_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0306-4522(94)90607-6","article-title":"Nitric oxide synthase immunoreactivity in rat pontine medullary neurons","volume":"59","author":"Dun","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2026.106202_bib51","doi-asserted-by":"crossref","first-page":"39201","DOI":"10.1074\/jbc.M110.118000","article-title":"Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter","volume":"285","author":"El-Kasaby","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib52","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1126\/science.178.4059.414","article-title":"Brain serotonin content: physiological regulation by plasma neutral amino acids","volume":"178","author":"Fernstrom","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106202_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-386467-3.00009-1","article-title":"Selective inhibitors of monoamine oxidase type B and the \u201ccheese effect\u201d","volume":"100","author":"Finberg","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106202_bib54","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0024-3205(89)90128-8","article-title":"The role of the 5-HT2 receptor in the regulation of sexual performance of male rats","volume":"45","author":"Foreman","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2026.106202_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00210-019-01779-z","article-title":"cGMP: a unique 2nd messenger molecule\u2013recent developments in cGMP research and development","volume":"393","author":"Friebe","year":"2020","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuint.2026.106202_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphys.2024.100117","article-title":"Functional and pathological consequences of being fast on the uptake: protein kinase G and p38\u03b1 MAPK regulation of serotonin transporters","volume":"7","author":"Gajeswski-Kurdziel","year":"2024","journal-title":"Curr. Res. Physiol."},{"key":"10.1016\/j.neuint.2026.106202_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1472-8206.1996.tb00145.x","article-title":"Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies","volume":"10","author":"Gardier","year":"1996","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib58","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1476-5381.1995.tb15919.x","article-title":"Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT","volume":"115","author":"Gartside","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib59","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/ejn.14713","article-title":"A role for nitric oxide in serotonin neurons of the midbrain raphe nuclei","volume":"51","author":"Gartside","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib60","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/2041318a0","article-title":"Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds","volume":"204","author":"Glowinski","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2026.106202_bib61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/17460441.2019.1546691","article-title":"Vortioxetine: a novel antidepressant for the treatment of major depressive disorder","volume":"14","author":"Gonda","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.neuint.2026.106202_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jad.2017.05.048","article-title":"Emotional blunting with antidepressant treatments: a survey among depressed patients","volume":"221","author":"Goodwin","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuint.2026.106202_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40560-018-0329-1","article-title":"Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose","volume":"6","author":"Groot","year":"2018","journal-title":"J. Intensiv. Care"},{"key":"10.1016\/j.neuint.2026.106202_bib64","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1042\/bst0290722","article-title":"Regulation of the serotonin transporter by interacting proteins","volume":"29","author":"Haase","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuint.2026.106202_bib65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10253899909001117","article-title":"Attenuation of 8-OH-DPAT-induced decreases in 5-HT synthesis in brain regions of rats adapted to a repeated stress schedule","volume":"3","author":"Haleem","year":"1999","journal-title":"Stress"},{"key":"10.1016\/j.neuint.2026.106202_bib66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbrc.2023.04.028","article-title":"S-Palmitoylation of the serotonin transporter promotes its cell surface expression and serotonin uptake","volume":"662","author":"Harada","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2026.106202_bib67","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1021\/jm040793q","article-title":"Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT1A receptor agonists and serotonin reuptake inhibitors","volume":"47","author":"Heinrich","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib68","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1016\/j.bmc.2004.07.014","article-title":"Dual 5-HT1A agonists and 5-HT reuptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity","volume":"12","author":"Heinrich","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib69","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1523\/JNEUROSCI.2618-20.2021","article-title":"Inflammation-induced histamine impairs the capacity of escitalopram to increase hippocampal extracellular serotonin","volume":"41","author":"Hersey","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0893-133X(00)00175-5","article-title":"Desensitization of 5-HT1A autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635","volume":"24","author":"Herv\u00e1s","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2026.106202_bib71","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1200\/JCO.1989.7.6.700","article-title":"GR 38032F (GR-C507\/75): a novel compound effective in the prevention of acute cisplatin-induced emesis","volume":"7","author":"Hesketh","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neuint.2026.106202_bib72","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00179315","article-title":"The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo","volume":"338","author":"Hjorth","year":"1988","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuint.2026.106202_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108246","article-title":"Disrupting the physical interaction between serotonin transporter and soluble guanylate cyclase produces a fast-acting antidepressant activity","volume":"229","author":"Huang","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuint.2026.106202_bib74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(94)90344-1","article-title":"Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors","volume":"260","author":"Invernizzi","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-8993(95)00730-E","article-title":"Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram","volume":"696","author":"Invernizzi","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2026.106202_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112266","article-title":"The role of nitric oxide and hormone signaling in chronic stress, anxiety, depression and post-traumatic stress disorder","volume":"590","author":"Jankovic","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.neuint.2026.106202_bib77","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1124\/mol.104.009555","article-title":"Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation","volume":"67","author":"Jayanthi","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib78","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0006-291X(02)00460-6","article-title":"Interaction of the C-terminal region of the rat serotonin transporter with MacMARCKS modulates 5-HT uptake regulation by protein kinase C","volume":"294","author":"Jess","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2026.106202_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65202-3","article-title":"Structural basis of vilazodone dual binding mode to the serotonin transporter","volume":"16","author":"Kalenderoglou","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2026.106202_bib80","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pharmthera.2005.12.004","article-title":"5-hydroxytryptamine receptors in the human cardiovascular system","volume":"111","author":"Kaumann","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2026.106202_bib81","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/1570159X14666151208113700","article-title":"Inflammation in depression and the potential for anti-inflammatory treatment","volume":"14","author":"K\u00f6hler","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-4547(19961215)46:6<697::AID-JNR7>3.0.CO;2-A","article-title":"Ultrastructural localization of 5-hydroxytryptamine-1A receptors in the rat brain","volume":"46","author":"Kia","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2026.106202_bib83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02246293","article-title":"Clozapine acts as a 5-HT2 antagonist by attenuating DOI-induced inhibition of male rat sexual behaviour","volume":"119","author":"Klint","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuint.2026.106202_bib84","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.ATV.20.10.2233","article-title":"High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy","volume":"20","author":"K\u00e9reveur","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neuint.2026.106202_bib85","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuint.2026.106202_bib86","first-page":"459","article-title":"The treatment of depressive states with G22355 (imipramine hydrochloride)","volume":"115","author":"Kuhn","year":"1958","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.neuint.2026.106202_bib87","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1124\/mol.118.113530","article-title":"Modeling and mutational analysis of the binding mode for the multimodal antidepressant drug vortioxetine to the human 5-HT3A receptor","volume":"94","author":"Ladefoged","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib88","doi-asserted-by":"crossref","first-page":"11344","DOI":"10.1016\/S0021-9258(19)49916-X","article-title":"One-step purification of the serotonin transporter located at the human platelet plasma membrane","volume":"267","author":"Launay","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00176767","article-title":"Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine","volume":"352","author":"Le Poul","year":"1995","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuint.2026.106202_bib90","first-page":"354","article-title":"Ventricular fibrillation in a tetraplegic patient who had a therapeutic level of a tricyclic antidepressant","volume":"23","author":"Levin","year":"1985","journal-title":"Case Report. Paraplegia."},{"key":"10.1016\/j.neuint.2026.106202_bib91","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0022-3565(25)21219-8","article-title":"Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and Go proteins and in neuroendocrine responses to a 5-HT1A agonist","volume":"279","author":"Li","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2026.106202_bib92","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cercor\/bhr220","article-title":"5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons","volume":"22","author":"Llad\u00f3-Pelfort","year":"2012","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuint.2026.106202_bib93","first-page":"129","article-title":"A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer","volume":"8","author":"Loomer","year":"1957","journal-title":"Psychiatr. Res. Rep. Am. Psychiatr. Assoc."},{"key":"10.1016\/j.neuint.2026.106202_bib94","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-020-00315-3","article-title":"Recent advances in the development of protein\u2013protein interactions modulators: mechanisms and clinical trials","volume":"5","author":"Lu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuint.2026.106202_bib95","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/1873-3468.13765","article-title":"1-Stearoyl-2-docosahexaenoyl-phosphatidic acid interacts with and activates Praja-1, the E3 ubiquitin ligase acting on the serotonin transporter in the brain","volume":"594","author":"Lu","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2026.106202_bib96","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0773.1978.tb02229.x","article-title":"The effects of aromatic amino acid decarboxylase inhibitors on plasma concentrations of 5-hydroxytryptophan in man","volume":"43","author":"Magnussen","year":"1978","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.neuint.2026.106202_bib97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-2999(95)00573-4","article-title":"Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study","volume":"286","author":"Malagi\u00e9","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib98","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.106.022756","article-title":"Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain","volume":"70","author":"Mannoury la","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib99","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neubiorev.2014.03.001","article-title":"Controversies on the role of 5-HT2C receptors in the mechanisms of action of antidepressant drugs","volume":"42","author":"Martin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuint.2026.106202_bib100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-018-1294-2","article-title":"Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants","volume":"15","author":"Mart\u00edn-Hern\u00e1ndez","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2026.106202_bib101","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1476-5381.1961.tb01118.x","article-title":"Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo","volume":"17","author":"Maxwell","year":"1961","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.neuint.2026.106202_bib102","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016949","article-title":"Endocytosis and cancer","volume":"5","author":"Mellman","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.neuint.2026.106202_bib103","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.161.5.826","article-title":"Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study","volume":"161","author":"Meyer","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib104","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1017\/S1461145712001496","article-title":"On \u201cpolypharmacy\u201d and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal","volume":"17","author":"Millan","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib105","doi-asserted-by":"crossref","first-page":"27351","DOI":"10.1016\/S0021-9258(18)46992-X","article-title":"Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP","volume":"269","author":"Miller","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib106","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1476-5381.1986.tb10228.x","article-title":"Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism","volume":"88","author":"Miner","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib107","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4088\/JCP.v58n1005","article-title":"Pindolol augmentation of treatment-resistant depressed patients","volume":"58","author":"Moreno","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib108","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1523\/JNEUROSCI.6458-11.2012","article-title":"MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation","volume":"32","author":"Mouri","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib109","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.mito.2010.04.007","article-title":"S-Nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration","volume":"10","author":"Nakamura","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neuint.2026.106202_bib110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2015.03.017","article-title":"Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases","volume":"84","author":"Nakamura","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2026.106202_bib111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0447.1993.tb03370.x","article-title":"A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder","volume":"87","author":"Nielsen","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuint.2026.106202_bib112","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1152\/ajplegacy.1971.221.6.1629","article-title":"Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection","volume":"221","author":"Oldendorf","year":"1971","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuint.2026.106202_bib113","first-page":"PL345","article-title":"The ovarian and cervical regions of the rat uterus display a different contractile response to serotonin and prostaglandin F2alpha. I. The estrous cycle","volume":"66","author":"Oropeza","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2026.106202_bib114","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1101\/lm.1114808","article-title":"The NO-cGMP-PKG signaling pathway regulates synaptic plasticity and fear memory consolidation in the lateral amygdala via activation of ERK\/MAP kinase","volume":"15","author":"Ota","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuint.2026.106202_bib115","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0024-3205(92)90423-M","article-title":"Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum","volume":"50","author":"Perry","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2026.106202_bib116","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41467-020-15292-y","article-title":"The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter","volume":"11","author":"Plenge","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2026.106202_bib117","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1038\/s41467-021-25363-3","article-title":"The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter","volume":"12","author":"Plenge","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2026.106202_bib118","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/BF02041242","article-title":"The discovery of antidepressants: a winding path","volume":"47","author":"Pletscher","year":"1991","journal-title":"Experientia"},{"key":"10.1016\/j.neuint.2026.106202_bib119","doi-asserted-by":"crossref","first-page":"11545","DOI":"10.1073\/pnas.0501432102","article-title":"Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase","volume":"102","author":"Prasad","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2026.106202_bib120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.56.4.375","article-title":"A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius","volume":"56","author":"P\u00e9rez","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1523\/JNEUROSCI.17-01-00045.1997","article-title":"Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression","volume":"17","author":"Qian","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib122","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0736-5748(02)00021-7","article-title":"Role of syntaxin 1A on serotonin transporter expression in developing thalamocortical neurons","volume":"20","author":"Quick","year":"2002","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib123","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jad.2021.10.041","article-title":"Comparative effects of 15 antidepressants on the risk of withdrawal syndrome: a real-world study using the WHO pharmacovigilance database","volume":"297","author":"Quilichini","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuint.2026.106202_bib124","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1073\/pnas.90.6.2542","article-title":"Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization","volume":"90","author":"Ramamoorthy","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2026.106202_bib125","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1074\/jbc.273.4.2458","article-title":"Phosphorylation and regulation of antidepressant-sensitive serotonin transporters","volume":"273","author":"Ramamoorthy","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib126","doi-asserted-by":"crossref","first-page":"11639","DOI":"10.1074\/jbc.M611353200","article-title":"Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP","volume":"282","author":"Ramamoorthy","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib127","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pharmthera.2010.09.009","article-title":"Regulation of monoamine transporters: role of transporter phosphorylation","volume":"129","author":"Ramamoorthy","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2026.106202_bib128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.285.5428.763","article-title":"Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants","volume":"285","author":"Ramamoorthy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106202_bib129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cbpa.2018.06.004","article-title":"Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area","volume":"44","author":"Ran","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuint.2026.106202_bib130","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1017\/S204579602500023X","article-title":"Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis","volume":"34","author":"Rennwald","year":"2025","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.neuint.2026.106202_bib131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A","article-title":"Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain","volume":"417","author":"Riad","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2026.106202_bib132","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/17410541.6.2.217","article-title":"Vilazodone, a novel, dual-acting antidepressant: current status, future promise and potential for individualized treatment of depression","volume":"6","author":"Rickels","year":"2009","journal-title":"Pers. Med."},{"key":"10.1016\/j.neuint.2026.106202_bib133","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4088\/JCP.08m04637","article-title":"Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial","volume":"70","author":"Rickels","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib134","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s00018-006-6112-9","article-title":"Cell communication in taste buds","volume":"63","author":"Roper","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2026.106202_bib135","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2026.106202_bib136","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1046\/j.1471-4159.1997.68062618.x","article-title":"Modulation of serotonin transporter activity by a protein kinase C activator and an inhibitor of type 1 and 2A serine\/threonine phosphatases","volume":"68","author":"Sakai","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2026.106202_bib137","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304089120","article-title":"Dynamic extracellular vestibule of human SERT: unveiling druggable potential with high-affinity allosteric inhibitors","volume":"120","author":"Salomon","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2026.106202_bib138","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1523\/JNEUROSCI.3754-04.2005","article-title":"A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression","volume":"25","author":"Samuvel","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib139","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2026.106202_bib140","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin 1A and serotonin 2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuint.2026.106202_bib141","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1468-2982.2000.00146.x","article-title":"Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks","volume":"20","author":"Sarchielli","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuint.2026.106202_bib142","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd.2016.29","article-title":"Small molecules, big targets: drug discovery faces the protein\u2013protein interaction challenge","volume":"15","author":"Scott","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuint.2026.106202_bib143","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/npp.2012.58","article-title":"Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial","volume":"37","author":"Sepanjnia","year":"2012","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neuint.2026.106202_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2019.06.005","article-title":"5-hydroxytryptophan: a precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology","volume":"146","author":"Sharma","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuint.2026.106202_bib145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.pharep.2017.01.030","article-title":"Vortioxetine: a review of the pharmacology and clinical profile of the novel antidepressant","volume":"69","author":"Sowa-Ku\u0107ma","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuint.2026.106202_bib146","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0028-3908(63)90037-6","article-title":"Association of behavioural effects of pargyline, a non-hydrazide mao inhibitor with increase in brain norepinephrine","volume":"2","author":"Spector","year":"1963","journal-title":"Int. J. Neuropharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib147","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/cb4007198","article-title":"Characterization of intracellular regions in the human serotonin transporter for phosphorylation sites","volume":"9","author":"S\u00f8rensen","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neuint.2026.106202_bib148","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors: serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuint.2026.106202_bib149","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-2007-979551","article-title":"Delayed onset of action of antidepressant drugs? Survey of results of Zurich Meta-Analyses","volume":"29","author":"Stassen","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-6606-2-26","article-title":"cGMP-dependent protein kinase I\u03b1 associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake","volume":"2","author":"Steiner","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuint.2026.106202_bib151","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M112.408237","article-title":"Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C","volume":"288","author":"Sucic","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib152","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.abo3566","article-title":"Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN","volume":"378","author":"Sun","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106202_bib153","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1074\/jbc.274.25.17551","article-title":"Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter","volume":"274","author":"Tate","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib154","doi-asserted-by":"crossref","first-page":"26303","DOI":"10.1016\/S0021-9258(18)47194-3","article-title":"The effect of N-linked glycosylation on activity of the Na+ and Cl- dependent serotonin transporter expressed using recombinant baculovirus in insect cells","volume":"269","author":"Tate","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib155","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","article-title":"Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis","volume":"63","author":"Taylor","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib156","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmet.2007.09.012","article-title":"Serotonin and the orchestration of energy balance","volume":"6","author":"Tecott","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuint.2026.106202_bib157","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00139709-200524030-00013","article-title":"Tricyclic antidepressant poisoning : cardiovascular toxicity","volume":"24","author":"Thanacoody","year":"2005","journal-title":"Toxicol. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2026.106202_bib158","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/hup.386","article-title":"Onset of action of antidepressants: results of different analyses","volume":"17","author":"Thompson","year":"2002","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib159","article-title":"Neuronal nitric oxide synthase expressing neurons: a journey from birth to neuronal circuits","volume":"6","author":"Tricoire","year":"2012","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuint.2026.106202_bib160","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2026.106202_bib161","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4088\/JCP.v69n0211","article-title":"Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression","volume":"69","author":"Trivedi","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib162","first-page":"28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR\u2217D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Aust. J. Pharm."},{"key":"10.1016\/j.neuint.2026.106202_bib163","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pharmthera.2005.06.004","article-title":"Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan","volume":"109","author":"Turner","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2026.106202_bib164","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib165","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/j.pain.0000000000002952","article-title":"Cingulate cGMP-dependent protein kinase I facilitates chronic pain and pain-related anxiety and depression","volume":"164","author":"Wang","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.neuint.2026.106202_bib166","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1460-9568.2006.04900.x","article-title":"Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein","volume":"24","author":"Wersinger","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib167","article-title":"Role of tyrosine nitrosylation in stress-induced major depressive disorder: mechanisms and implications","volume":"24","author":"Wilson","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.neuint.2026.106202_bib168","doi-asserted-by":"crossref","first-page":"36051","DOI":"10.1074\/jbc.M112.394726","article-title":"Cyclic GMP-dependent stimulation of serotonin transport does not involve direct transporter phosphorylation by cGMP-dependent protein kinase","volume":"287","author":"Wong","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib169","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","article-title":"Clinical pharmacology of MAO inhibitors: safety and future","volume":"25","author":"Yamada","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2026.106202_bib170","doi-asserted-by":"crossref","first-page":"eabl3857","DOI":"10.1126\/sciadv.abl3857","article-title":"Illumination of serotonin transporter mechanism and role of the allosteric site","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuint.2026.106202_bib171","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","article-title":"Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen","volume":"65","author":"Yildiz","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib172","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/jnnp.44.4.323","article-title":"Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid","volume":"44","author":"Young","year":"1981","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuint.2026.106202_bib173","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/srep01753","article-title":"The role of aromatic L-amino acid decarboxylase in bacillamide C biosynthesis by bacillus atrophaeus C89","volume":"3","author":"Yuwen","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2026.106202_bib174","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1097540","article-title":"Tryptophan hydroxylase-2 controls brain serotonin synthesis","volume":"305","author":"Zhang","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106202_bib175","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1523\/JNEUROSCI.0034-07.2007","article-title":"Serotonin transporter phosphorylation by cGMP-dependent protein kinase is altered by a mutation associated with obsessive\u2013compulsive disorder","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2026.106202_bib176","first-page":"E2776","article-title":"Control of serotonin transporter phosphorylation by conformational state","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2026.106202_bib177","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1074\/jbc.M110.203935","article-title":"Myristoylation of cGMP-dependent protein kinase dictates isoform specificity for serotonin transporter regulation","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib178","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5582\/bst.2015.01168","article-title":"Lipopolysaccharide-induced serotonin transporter up-regulation involves PKG-I and p38MAPK activation partially through A3 adenosine receptor","volume":"9","author":"Zhao","year":"2015","journal-title":"BioSci. Trend."},{"key":"10.1016\/j.neuint.2026.106202_bib179","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.2245","article-title":"Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95","volume":"16","author":"Zhou","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2026.106202_bib180","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","article-title":"The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters","volume":"31","author":"Zhu","year":"2006","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neuint.2026.106202_bib181","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1074\/jbc.M410858200","article-title":"p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process","volume":"280","author":"Zhu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2026.106202_bib182","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1124\/mol.65.6.1462","article-title":"Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation","volume":"65","author":"Zhu","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2026.106202_bib183","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/npp.2010.116","article-title":"Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters","volume":"35","author":"Zhu","year":"2010","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neuint.2026.106202_bib184","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.107.121665","article-title":"Rapid stimulation of presynaptic serotonin transport by A3 adenosine receptors","volume":"322","author":"Zhu","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuint.2026.106202_bib185","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm.3644","article-title":"CAPON-nNOS coupling can serve as a target for developing new anxiolytics","volume":"20","author":"Zhu","year":"2014","journal-title":"Nat. Med."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626000938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626000938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:01:19Z","timestamp":1783443679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018626000938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":185,"alternative-id":["S0197018626000938"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106202","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An emerging therapeutic strategy for major depressive disorder: targeting the protein-protein interactions","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106202"}}